Dinesh Khanna, MBBS, M.Sc.

Patient-reported outcomes in scleroderma

Dr. Khanna directs a multidisciplinary group of caregivers, scientists, and clinical researchers dedicated to advancing knowledge about scleroderma and related conditions. His research interests include developing new patient-reported outcome measures in patients with scleroderma and different diseases of the joint, and clinical trial design in evaluating new treatments for scleroderma. In addition, he is leading international efforts to develop guidelines for the management of scleroderma and gout.

M.B.B.S., University College of Medical Sciences
M.Sc., Clinical Research, University of California, Los Angeles

In the News

Patients with rare scleroderma have deadlier organ damage, despite getting standard treatment

For scleroderma, algorithm helps better screen for fatal complication

Repurposing tocilizumab in scleroderma patients may prevent early lung disease

Dinesh Khanna receives Service Spotlight in Michigan Medicine Headlines

Drug does not reduce digital ulcers in patients with systemic sclerosis

Health Services Research and Policy Focus

Healthcare Quality

Healthcare Quality Clinical Guidelines

Healthcare Quality Health Outcomes

Condition Focus

Infectious, Immunologic, and Allergic Diseases

Infectious, Immunologic, and Allergic Diseases Autoimmune and Systemic Inflammatory Diseases

Musculoskeletal and Skin Disorders

Musculoskeletal and Skin Disorders Dermatologic Conditions

U-M Academic Affiliation(s)

Medical School

Medical School Internal Medicine

Medical School Internal Medicine Rheumatology